TransPerfect Life Sciences Announces eCOA LingCert Program
NEW YORK, March 1, 2023 /PRNewswire/ -- TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced the rollout of its certification solution for accrediting electronic clinical outcome assessment (eCOA) technology platforms based on their ability to host eCOA localized materials according to industry standards, best practices, and sponsor needs.
- The solution, called eCOA LingCert, has three certification levels: Silver, Gold, and Platinum.
- With this certification, eCOA platforms are also well-positioned to reduce translation costs and enhance overall eCOA quality by aligning with and meeting sponsor expectations.
- TransPerfect President and CEO Phil Shawe stated, "We're excited to now offer the eCOA LingCert accreditation program.
- This certification gives our life sciences clients and partners a standardized approach to hosting localized eCOA materials."